Show simple item record

dc.contributor.advisorJohn Haran, MD
dc.contributor.authorHaran, John P
dc.contributor.authorWu, Gregory
dc.contributor.authorBucci, V.
dc.contributor.authorFischer, A.
dc.contributor.authorKeang, L.
dc.contributor.authorBoyer, Edward W.
dc.contributor.authorHibberd, P. L.
dc.date2022-08-11T08:10:55.000
dc.date.accessioned2022-08-23T17:24:58Z
dc.date.available2022-08-23T17:24:58Z
dc.date.issued2016-07-01
dc.date.submitted2017-05-16
dc.identifier.citationEpidemiol Infect. 2016 Jul;144(10):2176-83. doi: 10.1017/S0950268816000200. <a href="https://doi.org/10.1017/S0950268816000200">Link to article on publisher's site</a>
dc.identifier.issn0950-2688 (Linking)
dc.identifier.doi10.1017/S0950268816000200
dc.identifier.pmid27324463
dc.identifier.urihttp://hdl.handle.net/20.500.14038/49306
dc.description<p>Gregory Wu participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School. </p>
dc.description.abstractClostridium difficile diarrhoea is an urgent threat to patients, but little is known about the role of antibiotic administration that starts in emergency department observation units (EDOUs). We studied risk factors for antibiotic-associated diarrhoea (AAD) and C. difficile infection (CDI) in EDOU patients. This prospective cohort study enrolled adult patients discharged after EDOU antibiotic treatment between January 2013 and 2014. We obtained medical histories, EDOU treatment and occurrence of AAD and CDI over 28 days after discharge. We enrolled and followed 275 patients treated with antibiotics in the EDOU. We found that 52 (18.6%) developed AAD and four (1.5%) had CDI. Patients treated with vancomycin [relative risk (RR) 0.52, 95% confidence interval (CI) 0.3-0.9] were less likely to develop AAD. History of developing diarrhoea with antibiotics (RR 3.11, 95% CI 1.92-5.03) and currently failing antibiotics (RR 1.90, 95% CI 1.14-3.16) were also predictors of AAD. Patients with CDI were likely to be treated with clindamycin. In conclusion, AAD occurred in almost 20% of EDOU patients with risk factors including a previous history of diarrhoea with antibiotics and prior antibiotic therapy, while the risk of AAD was lower in patients receiving treatment regimens utilizing intravenous vancomycin.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=27324463&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1017/S0950268816000200
dc.subjectantibiotics
dc.subjectclostridium difficile
dc.subjectdiarrhea
dc.subjectgastrointestinal infections
dc.subjectinfectious disease
dc.subjectBacterial Infections and Mycoses
dc.subjectEmergency Medicine
dc.subjectHealth Services Administration
dc.subjectMedical Education
dc.titleAntibiotic-associated diarrhoea in emergency department observation unit patients
dc.typeJournal Article
dc.source.journaltitleEpidemiology and infection
dc.source.volume144
dc.source.issue10
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/ssp/247
dc.identifier.contextkey10171205
html.description.abstract<p>Clostridium difficile diarrhoea is an urgent threat to patients, but little is known about the role of antibiotic administration that starts in emergency department observation units (EDOUs). We studied risk factors for antibiotic-associated diarrhoea (AAD) and C. difficile infection (CDI) in EDOU patients. This prospective cohort study enrolled adult patients discharged after EDOU antibiotic treatment between January 2013 and 2014. We obtained medical histories, EDOU treatment and occurrence of AAD and CDI over 28 days after discharge. We enrolled and followed 275 patients treated with antibiotics in the EDOU. We found that 52 (18.6%) developed AAD and four (1.5%) had CDI. Patients treated with vancomycin [relative risk (RR) 0.52, 95% confidence interval (CI) 0.3-0.9] were less likely to develop AAD. History of developing diarrhoea with antibiotics (RR 3.11, 95% CI 1.92-5.03) and currently failing antibiotics (RR 1.90, 95% CI 1.14-3.16) were also predictors of AAD. Patients with CDI were likely to be treated with clindamycin. In conclusion, AAD occurred in almost 20% of EDOU patients with risk factors including a previous history of diarrhoea with antibiotics and prior antibiotic therapy, while the risk of AAD was lower in patients receiving treatment regimens utilizing intravenous vancomycin.</p>
dc.identifier.submissionpathssp/247
dc.contributor.departmentSenior Scholars Program
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentDepartment of Emergency Medicine
dc.source.pages2176-83


This item appears in the following Collection(s)

Show simple item record